Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Community - Associated Extended-spectrum Beta-lactamases (ESBL)

NCT00363220 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00363220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00363220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Completed
Start date
August 31, 2006
Completion date
December 31, 2015
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

e coli infections, infection, klebsiella infections, proteus infections